Sakode, CM and Padhi, R and Kapoor, S and Rallabandi, VPS and Roy, PK (2014) Multimodal therapy for complete regression of malignant melanoma using constrained nonlinear optimal dynamic inversion. In: BIOMEDICAL SIGNAL PROCESSING AND CONTROL, 13 . pp. 198-211.
bio_sig_pro_con_13_198_2014.pdf - Published Version
Restricted to Registered users only
Download (2494Kb) | Request a copy
Using a realistic nonlinear mathematical model for melanoma dynamics and the technique of optimal dynamic inversion (exact feedback linearization with static optimization), a multimodal automatic drug dosage strategy is proposed in this paper for complete regression of melanoma cancer in humans. The proposed strategy computes different drug dosages and gives a nonlinear state feedback solution for driving the number of cancer cells to zero. However, it is observed that when tumor is regressed to certain value, then there is no need of external drug dosages as immune system and other therapeutic states are able to regress tumor at a sufficiently fast rate which is more than exponential rate. As model has three different drug dosages, after applying dynamic inversion philosophy, drug dosages can be selected in optimized manner without crossing their toxicity limits. The combination of drug dosages is decided by appropriately selecting the control design parameter values based on physical constraints. The process is automated for all possible combinations of the chemotherapy and immunotherapy drug dosages with preferential emphasis of having maximum possible variety of drug inputs at any given point of time. Simulation study with a standard patient model shows that tumor cells are regressed from 2 x 107 to order of 105 cells because of external drug dosages in 36.93 days. After this no external drug dosages are required as immune system and other therapeutic states are able to regress tumor at greater than exponential rate and hence, tumor goes to zero (less than 0.01) in 48.77 days and healthy immune system of the patient is restored. Study with different chemotherapy drug resistance value is also carried out. (C) 2014 Elsevier Ltd. All rights reserved.
|Item Type:||Journal Article|
|Additional Information:||Copy right for this article belongs to the ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND|
|Keywords:||Chemotherapy; Immunotherapy; Multimodal therapy; Automatic drug delivery; Optimal drug dosage; Treatment of melanoma; Regression of melanoma|
|Department/Centre:||Division of Mechanical Sciences > Aerospace Engineering (Formerly, Aeronautical Engineering)|
|Date Deposited:||03 Sep 2014 10:51|
|Last Modified:||03 Sep 2014 10:51|
Actions (login required)